This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract has a ceiling value of $2,040.00 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) vehicle with the Department of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $2,208.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting a variety of infectious diseases, including COVID-19, influenza, and sexually transmitted diseases....
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract, worth $2,720.00, is a firm fixed-price delivery order with a period of performance ending on March 7, 2025. Cepheid has been awarded this contract as a prime contractor, and the contract is not designated as a set-aside....
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a delivery order worth $4,539.30 with a firm fixed price pricing type and an ultimate completion date of April 18, 2025. Cepheid, the prime contractor, will provide molecular diagnostic testing solutions, including GeneXpert diagnostic systems, reagents, test kits, and maintenance services, to support the detection of infectious diseases...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
The U.S. Defense Logistics Agency (DLA) awarded a $10,880.00 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, with a completion date of February 13, 2025, is for the provision of XPCOV2/FLU/RSV-10 molecular diagnostic products and services, including GeneXpert diagnostic systems, reagents, test kits, and maintenance. This award is part of a larger Indefinite Delivery Contract vehicle with the Department of Veterans...